292 related articles for article (PubMed ID: 21166558)
21. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
Pamukcu B; Lip GY
Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
[TBL] [Abstract][Full Text] [Related]
22. Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation.
Singla S; Karam P; Deshmukh AJ; Mehta J; Paydak H
J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):12-20. PubMed ID: 21335483
[TBL] [Abstract][Full Text] [Related]
23. Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation.
Duray GZ; Ehrlich JR; Hohnloser SH
Curr Opin Cardiol; 2010 Jan; 25(1):53-8. PubMed ID: 19881340
[TBL] [Abstract][Full Text] [Related]
24. A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion.
Torp-Pedersen C; Raev DH; Dickinson G; Butterfield NN; Mangal B; Beatch GN
Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):637-43. PubMed ID: 21841207
[TBL] [Abstract][Full Text] [Related]
25. Dronedarone: an overview.
Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093
[TBL] [Abstract][Full Text] [Related]
26. Amiodarone as paradigm for developing new drugs for atrial fibrillation.
Singh BN
J Cardiovasc Pharmacol; 2008 Oct; 52(4):300-5. PubMed ID: 18841075
[TBL] [Abstract][Full Text] [Related]
27. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
[TBL] [Abstract][Full Text] [Related]
28. New antiarrhythmic treatment of atrial fibrillation.
Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):707-14. PubMed ID: 17605649
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant therapy for atrial fibrillation.
Mohammed KS; Kowey PR; Musco S
Future Cardiol; 2010 Jan; 6(1):67-81. PubMed ID: 20014988
[TBL] [Abstract][Full Text] [Related]
30. Vernakalant. Too dangerous in atrial fibrillation.
Prescrire Int; 2012 May; 21(127):119-22. PubMed ID: 22827000
[TBL] [Abstract][Full Text] [Related]
31. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
Wegener FT; Ehrlich JR; Hohnloser SH
J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
[TBL] [Abstract][Full Text] [Related]
32. Dronedarone for atrial fibrillation therapy.
Marzocchi M; Lombardi F
Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):675-83. PubMed ID: 21714598
[TBL] [Abstract][Full Text] [Related]
33. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):24S-30S. PubMed ID: 21098416
[TBL] [Abstract][Full Text] [Related]
34. A new antiarrhythmic drug in the treatment of recent-onset atrial fibrillation: vernakalant.
Vizzardi E; Salghetti F; Bonadei I; Gelsomino S; Lorusso R; D'Aloia A; Curnis A
Cardiovasc Ther; 2013 Oct; 31(5):e55-62. PubMed ID: 23398692
[TBL] [Abstract][Full Text] [Related]
35. Dronedarone: a new antiarrhythmic agent.
Oyetayo OO; Rogers CE; Hofmann PO
Pharmacotherapy; 2010 Sep; 30(9):904-15. PubMed ID: 20795846
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of dronedarone: a review of randomized trials.
Christiansen CB; Torp-Pedersen C; Køber L
Expert Opin Drug Saf; 2010 Jan; 9(1):189-99. PubMed ID: 20001756
[TBL] [Abstract][Full Text] [Related]
37. Atrial fibrillation and the expanding role of catheter ablation: do antiarrhythmic drugs have a future?
Naccarelli GV; Gonzalez MD
J Cardiovasc Pharmacol; 2008 Sep; 52(3):203-9. PubMed ID: 18806600
[TBL] [Abstract][Full Text] [Related]
38. Dronedarone. atrial fibrillation: too many questions about long-term adverse effects.
Prescrire Int; 2010 Aug; 19(108):149-52. PubMed ID: 20939439
[TBL] [Abstract][Full Text] [Related]
39. Is vernakalant better or not, compared with other treatments for conversion of acute atrial fibrillation?
Conde D
Int J Cardiol; 2013 Oct; 169(2):95-6. PubMed ID: 24071384
[TBL] [Abstract][Full Text] [Related]
40. Antiarrhythmic drugs for atrial fibrillation.
Marinelli A; Capucci A
Expert Opin Pharmacother; 2011 Jun; 12(8):1201-15. PubMed ID: 21323608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]